Sionna Therapeutics, Inc.
SIONUnited States
6 filed reports · 195 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
6 reports · Mar 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 5 | 812 | Mar 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 497 | Dec 2025 |
Documents
Financial data
195 concepts · 1,309 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial191 concepts · 1,271 facts · Dec 2023 to Jul 2026
- Accretion amortization of discounts and premiums investments12 · Mar 2024 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Mar 2024 to Jun 2026
- Allocated share based compensation expense12 · Mar 2024 to Jun 2026
- Cash and cash equivalents at carrying value12 · Mar 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents12 · Mar 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect12 · Mar 2024 to Jun 2026
- Comprehensive income net of tax12 · Mar 2024 to Jun 2026
- Conversion of stock amount converted112 · Mar 2024 to Jun 2026
- Debt securities available for sale realized gain loss12 · Mar 2024 to Jun 2026
- Depreciation12 · Mar 2024 to Jun 2026
- General and administrative expense (US GAAP)12 · Mar 2024 to Jun 2026
- Increase decrease in accounts payable12 · Mar 2024 to Jun 2026
- Increase decrease in accrued liabilities12 · Mar 2024 to Jun 2026
- Increase decrease in operating lease liability12 · Mar 2024 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets12 · Mar 2024 to Jun 2026
- Investment income interest12 · Mar 2024 to Jun 2026
- Net cash provided by used in financing activities12 · Mar 2024 to Jun 2026
- Net cash provided by used in investing activities12 · Mar 2024 to Jun 2026
- Net cash provided by used in operating activities12 · Mar 2024 to Jun 2026
- Net income loss12 · Mar 2024 to Jun 2026
- Nonoperating income expense12 · Mar 2024 to Jun 2026
- Offering costs transferred to additional paid in capital12 · Mar 2024 to Jun 2026
- Operating expenses (US GAAP)12 · Mar 2024 to Jun 2026
- Operating income loss12 · Mar 2024 to Jun 2026
Segment4 concepts · 38 facts · Mar 2024 to Jun 2026
- Net income loss12 · Mar 2024 to Jun 2026
- Reportable Segment12 · Mar 2024 to Jun 2026
- Segment reporting other item amount12 · Mar 2024 to Jun 2026
- Fees paid to licensors2 · Dec 2024 to Dec 2025
Segments
38 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 38 facts
- Reportable38 · Mar 2024 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.